NEOPLASMS, LUNG
Clinical trials for NEOPLASMS, LUNG explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, LUNG trials appear
Sign up with your email to follow new studies for NEOPLASMS, LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets lung cancer protein, aims to shrink tumors and extend life
Disease control Recruiting nowThis study tests a new medicine called Risvutatug rezetecan (Ris-Rez) that targets a specific protein (B7-H3) on cancer cells to stop their growth. It is for adults with relapsed small cell lung cancer who have already tried one prior treatment. About 420 participants will be ran…
Matched conditions: NEOPLASMS, LUNG
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New program aims to boost quality of life for lung cancer survivors in rural areas
Symptom relief Recruiting nowThis study tests a special program designed to help people living in rural areas who have had lung cancer. The program focuses on improving quality of life, reducing stigma, and helping survivors stay engaged with their healthcare. About 300 participants will be randomly assigned…
Matched conditions: NEOPLASMS, LUNG
Phase: NA • Sponsor: Jerod L Stapleton, PhD • Aim: Symptom relief
Last updated Jun 10, 2026 13:29 UTC